SNYR (synergychc.com) Rega marang bathi mangsa ngarep
Synergy CHC Corp owns a portfolio of wellness brands with resilient demand, ensuring long-term asset utilization. The company's forward P/E ratio illustrates investor confidence trends, with the metric currently at 0.60. The holding company accumulates profitable beauty brands, creating a stable cash cow. Efficiency is maintained through a lean management team and the full outsourcing of operational processes.
Ringkesan rincian data analitis Synergy CHC Corporation (SNYR)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Synergy CHC Corp|SNYR - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Synergy CHC Corp|SNYR - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Synergy CHC Corp|SNYR - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan Synergy CHC|Likuiditas cepet synergychc.com
- rincian asil keuangan lan kelipatan valuasi:
SNYR - Bathi perusahaan|Proyeksi bathi mangsa ngarep Synergy CHC Corp|SNYR - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Synergy CHC Corp|SNYR - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Synergy CHC Corp|SNYR - Bathi operasional sadurunge potongan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Synergy CHC|SNYR - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan synergychc.com|SNYR - Tambahing bathi saben saham ing taun lumaku
Pambiji fundamental:SNYR Synergy CHC
The forward P/E reflects the ratio of the current market value of Synergy CHC Corp (SNYR) to its projected net income, allowing for an assessment of the cost of each dollar of expected earnings. This expected price-to-earnings multiple for the company separates speculative noise from fundamental value by accounting for the efficiency of the issuer's contract manufacturing and logistics hubs, helping investors determine the degree of undervaluation or the risk of overpaying for the asset.
Pesaing utama
Prakiraan rega marang bathi HLN (Haleon)|KVUE (Kenvue Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma Corp VRNA|Jyong Bio (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|amneal.com - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech S.A. - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Technologies) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Galapagos Corp GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Amphastar Pharmaceuticals, Inc. AMPH|Kapitalisasi marang proyeksi bathi Pacira Pharmaceuticals (PCRX)|SPRY: Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Theravance Corp|Aquestive Therapeutics (AQST) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep SCPH|TECX (Tectonic Therapeutic Inc.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Tonix Pharma TNXP|Rega marang bathi mangsa ngarep China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E BHST (BioHarvest Sciences)|Pangali forward rega marang bathi invizyne.com|ORMP: Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Entera Bio Ltd.|HYFT (MindWalk) - Prakiraan rega marang bathi|ABVC BioPharma, Inc - Pangali mangsa ngarep rega marang bathi|CPIX (Cumberland Pharmaceuticals) - Pangali Forward P/E|Prakiraan rega marang bathi quantumbiopharma.com (QNTM)|Pangali Forward P/E FGEN|TELO (Telomir Pharmaceuticals Inc) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RANI (Rani Therapeutics Holdings, Inc.)|RLYB - Prakiraan rega marang bathi|LEXX: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi PULM (pulmatrix.com)|PTHL: Pangali Forward P/E|Prakiraan rega marang bathi Aptorum Group|Rega marang bathi mangsa ngarep Lyra Therapeutics, Inc|Rasio prakiraan rega marang bathi Impact BioMedical, Inc. IBO|Rega marang bathi mangsa ngarep TNF Pharmaceuticals (TNFA)|YCBD (cbdmd.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep PainReform PRFX|CYTO (Altamira Therapeutics Ltd) - Rasio rega marang bathi sing dikarepake|LIPO - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi OptiNose Corp OPTN|Pieris Pharmaceuticals (PIRS) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep PROC|Prakiraan rega marang bathi PTPI|Rasio prakiraan rega marang bathi Qilian International Holding Group QLI|Rega marang bathi mangsa ngarep ACELYRIN, Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Pangali mangsa ngarep rega marang bathi
